Home › Funds › JOURNEY STRATEGIC WEALTH LLC › MDGL

JOURNEY STRATEGIC WEALTH LLC position in MDGL

MADRIGAL PHARMACEUTICALS INC · Health Care

JOURNEY STRATEGIC WEALTH LLC reported holding 12,829 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q1 2026 13F filing — a position valued at US$6.7M, representing 0.17% of its reported portfolio and ranking #41 among its reported holdings. JOURNEY STRATEGIC WEALTH LLC has disclosed MDGL holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

Latest position (Q1 2026)12.83K sh
Reported value held$6.72M
Portfolio Weight0.17%
First reportedQ3 2023
Last changeHold
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How JOURNEY STRATEGIC WEALTH LLC's MDGL position evolved

JOURNEY STRATEGIC WEALTH LLC first disclosed a stake in MDGL in Q3 2023 at 13,320 shares (US$1.9M). The position peaked in Q4 2025 at 12,829 shares, worth US$7.5M. Across 10 filings, JOURNEY STRATEGIC WEALTH LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q1 2026) shows 12,829 shares valued at US$6.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 13.32K $1.95M New
Q4 2023 13.32K $3.08M Hold
Q1 2024 13.32K $3.56M Hold
Q3 2024 13.33K $2.83M Hold
Q4 2024 13.08K $4.04M Reduce
Q1 2025 13.08K $4.33M Hold
Q2 2025 13.08K $3.96M Hold
Q3 2025 12.83K $5.88M Reduce
Q4 2025 12.83K $7.47M Hold
Q1 2026 12.83K $6.72M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDGL and 13F data

MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), Janus Henderson Group (US$1.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDGL

All MDGL fund holders →

FAQ

How long has JOURNEY STRATEGIC WEALTH LLC held MDGL?

JOURNEY STRATEGIC WEALTH LLC has disclosed MDGL holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

What is JOURNEY STRATEGIC WEALTH LLC's current position in MDGL?

As of Q1 2026, JOURNEY STRATEGIC WEALTH LLC holds 12.83K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $6.72M, representing 0.17% of its reported portfolio and ranking #41.

Has JOURNEY STRATEGIC WEALTH LLC been buying or selling MDGL?

In the latest 13F filing (Q1 2026), JOURNEY STRATEGIC WEALTH LLC held unchanged its position in MDGL. The position peaked in Q4 2025 at 12.83K shares.

Which other funds hold MDGL?

Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Janus Henderson Group, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.